Literature DB >> 21664233

Aldosterone resistance: structural and functional considerations and new perspectives.

Maria-Christina Zennaro1, Edwige-Ludiwyne Hubert, Fábio L Fernandes-Rosa.   

Abstract

Aldosterone plays an essential role in the maintenance of fluid and electrolyte homeostasis in the distal nephron. Loss-of-function mutations in two key components of the aldosterone response, the mineralocorticoid receptor and the epithelial sodium channel ENaC, lead to type 1 pseudohypoaldosteronism (PHA1), a rare genetic disease of aldosterone resistance characterized by salt wasting, dehydration, failure to thrive, hyperkalemia and metabolic acidosis. This review describes the clinical, biological and genetic characteristics of the different forms of PHA1 and highlights recent advances in the understanding of the pathogenesis of the disease. We will also discuss genotype-phenotype correlations and new clinical and genetic entities that may prove relevant for patient's care in neonates with renal salt losing syndromes and/or failure to thrive.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664233     DOI: 10.1016/j.mce.2011.04.023

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  An infant with hyponatremia, hyperkalemia, and metabolic acidosis associated with urinary tract infection: Answers.

Authors:  Bahriye Atmis; İhsan Turan; Engin Melek; Aysun Karabay Bayazit
Journal:  Pediatr Nephrol       Date:  2019-05-03       Impact factor: 3.714

2.  Severe hyperkalemia is rescued by low-potassium diet in renal βENaC-deficient mice.

Authors:  Emilie Boscardin; Romain Perrier; Chloé Sergi; Marc Maillard; Johannes Loffing; Dominique Loffing-Cueni; Robert Koesters; Bernard Claude Rossier; Edith Hummler
Journal:  Pflugers Arch       Date:  2017-05-31       Impact factor: 3.657

Review 3.  Dietary potassium restriction attenuates urinary sodium wasting in the generalized form of pseudohypoaldosteronism type 1.

Authors:  Masanori Adachi; Toshihiro Tajima; Koji Muroya
Journal:  CEN Case Rep       Date:  2020-01-03

4.  A Novel SCNN1A Variation in a Patient with Autosomal-recessive Pseudohypoaldosteronism Type 1

Authors:  Mohammed Ayed Huneif; Ziyad Hamad Alhazmy; Anas M. Shoomi; Mohammed A. Alghofely; Humariya Heena; Aziza M. Mushiba; Abdulhamid AlSaheel
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-04-08

5.  Pseudohypoaldosteronism in a neonate presenting as life-threatening arrhythmia.

Authors:  Sudeep K Rajpoot; Carlos Maggi; Amrit Bhangoo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-03-01

6.  Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.

Authors:  R Manipriya; B Umamaheswari; A Prakash; N Binu
Journal:  Indian J Nephrol       Date:  2018 Jan-Feb

7.  Clinical features and molecular basis of pseudohypoaldosteronism type 1.

Authors:  Toshihiro Tajima; Shuntaro Morikawa; Akie Nakamura
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

8.  Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.

Authors:  Nasifa Nur; Cameron Lang; Juanita K Hodax; Jose Bernardo Quintos
Journal:  Case Rep Pediatr       Date:  2017-04-18

Review 9.  CPT-cGMP Is A New Ligand of Epithelial Sodium Channels.

Authors:  Hong-Long Ji; Hong-Guang Nie; Yongchang Chang; Qizhou Lian; Shan-Lu Liu
Journal:  Int J Biol Sci       Date:  2016-01-28       Impact factor: 6.580

10.  Two Japanese patients with the renal form of pseudohypoaldosteronism type 1 caused by mutations of NR3C2.

Authors:  Shuntaro Morikawa; Nagisa Komatsu; Sonoko Sakata; Akari Nakamura-Utsunomiya; Satoshi Okada; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2015-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.